report - tell a friend

The Hermelin Brain Tumor Center at Henry Ford Hospital, founded in honor of David Hermelin – former U.S. Ambassador to Norway and a brain tumor patient at Henry Ford – has become a national leader in brain tumor treatment by making surgery safer and recovery faster, by creating new delivery methods, conducting ongoing research and continuing to be at the forefront of the world’s best brain tumor treatment. The Hermelin Brain Tumor Center has continually offered new treatment delivery options for brain tumor patients since 1993 when Henry Ford became the first site in Michigan and one of only nine medical institutions in the country to be selected as part of a National Cancer Institute funded brain tumor consortium. Known as the New Approaches to Brain Tumor Therapy (NABTT) consortium, the Hermelin Brain Tumor Center team works with Johns Hopkins, Massachusetts General and other world renown brain cancer programs to develop and deliver novel treatments for brain tumor patients.